nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A5—epilepsy syndrome	0.00373	0.0254	CbGpPWpGaD
Cefuroxime—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A1—epilepsy syndrome	0.00363	0.0247	CbGpPWpGaD
Cefuroxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A5—epilepsy syndrome	0.00346	0.0235	CbGpPWpGaD
Cefuroxime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A10—epilepsy syndrome	0.00341	0.0232	CbGpPWpGaD
Cefuroxime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A1—epilepsy syndrome	0.00337	0.023	CbGpPWpGaD
Cefuroxime—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC17A7—epilepsy syndrome	0.00332	0.0226	CbGpPWpGaD
Cefuroxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A10—epilepsy syndrome	0.00316	0.0215	CbGpPWpGaD
Cefuroxime—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A2—epilepsy syndrome	0.00309	0.021	CbGpPWpGaD
Cefuroxime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC17A7—epilepsy syndrome	0.00309	0.021	CbGpPWpGaD
Cefuroxime—Ceftriaxone—GLUL—epilepsy syndrome	0.00288	0.585	CrCbGaD
Cefuroxime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A2—epilepsy syndrome	0.00287	0.0195	CbGpPWpGaD
Cefuroxime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A2—epilepsy syndrome	0.00282	0.0192	CbGpPWpGaD
Cefuroxime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A6—epilepsy syndrome	0.00282	0.0192	CbGpPWpGaD
Cefuroxime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A3—epilepsy syndrome	0.00269	0.0183	CbGpPWpGaD
Cefuroxime—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A3—epilepsy syndrome	0.00263	0.0179	CbGpPWpGaD
Cefuroxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A2—epilepsy syndrome	0.00262	0.0178	CbGpPWpGaD
Cefuroxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A6—epilepsy syndrome	0.00262	0.0178	CbGpPWpGaD
Cefuroxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A3—epilepsy syndrome	0.0025	0.017	CbGpPWpGaD
Cefuroxime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A3—epilepsy syndrome	0.00244	0.0166	CbGpPWpGaD
Cefuroxime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A1—epilepsy syndrome	0.00214	0.0146	CbGpPWpGaD
Cefuroxime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—epilepsy syndrome	0.00214	0.0146	CbGpPWpGaD
Cefuroxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A1—epilepsy syndrome	0.00199	0.0135	CbGpPWpGaD
Cefuroxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—epilepsy syndrome	0.00199	0.0135	CbGpPWpGaD
Cefuroxime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A7—epilepsy syndrome	0.00196	0.0133	CbGpPWpGaD
Cefuroxime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—epilepsy syndrome	0.00182	0.0124	CbGpPWpGaD
Cefuroxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A7—epilepsy syndrome	0.00182	0.0124	CbGpPWpGaD
Cefuroxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—epilepsy syndrome	0.00169	0.0115	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.00167	0.0113	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.00167	0.0113	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.00167	0.0113	CbGpPWpGaD
Cefuroxime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—epilepsy syndrome	0.0016	0.0109	CbGpPWpGaD
Cefuroxime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—epilepsy syndrome	0.00155	0.0105	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.00155	0.0105	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.00155	0.0105	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.00155	0.0105	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.00152	0.0104	CbGpPWpGaD
Cefuroxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—epilepsy syndrome	0.00149	0.0101	CbGpPWpGaD
Cefuroxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—epilepsy syndrome	0.00144	0.00977	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.00141	0.00962	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	0.00126	0.00859	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	0.00126	0.00859	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	0.00126	0.00859	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	0.0012	0.00819	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	0.00117	0.00797	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	0.00117	0.00797	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	0.00117	0.00797	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	0.00112	0.0076	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.000982	0.00668	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.000956	0.00651	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.000956	0.00651	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000949	0.00646	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000949	0.00646	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.000911	0.0062	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.000888	0.00604	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.000888	0.00604	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000881	0.00599	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000881	0.00599	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.000875	0.00595	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000846	0.00576	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000846	0.00576	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000846	0.00576	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000813	0.00553	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.000812	0.00552	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000785	0.00534	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000785	0.00534	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000785	0.00534	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000774	0.00527	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000755	0.00513	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000718	0.00489	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.000716	0.00487	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000692	0.0047	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000677	0.0046	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.000665	0.00452	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000642	0.00437	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000641	0.00436	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000641	0.00436	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000641	0.00436	CbGpPWpGaD
Cefuroxime—Cefonicid—ALB—epilepsy syndrome	0.000639	0.13	CrCbGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000628	0.00427	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000616	0.00419	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000612	0.00416	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000612	0.00416	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000595	0.00405	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000595	0.00405	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000595	0.00405	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000572	0.00389	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000568	0.00386	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000568	0.00386	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000499	0.00339	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000486	0.00331	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000486	0.00331	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000464	0.00315	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000463	0.00315	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000451	0.00307	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000451	0.00307	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	0.000446	0.00303	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000445	0.00302	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000445	0.00302	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000445	0.00302	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000445	0.00302	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.00043	0.00293	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	0.000414	0.00281	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000413	0.00281	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000413	0.00281	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000413	0.00281	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000413	0.00281	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000413	0.00281	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000394	0.00268	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000389	0.00264	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000384	0.00261	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000378	0.00257	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000366	0.00249	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000364	0.00248	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	0.000363	0.00247	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000361	0.00245	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.000351	0.00239	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.000351	0.00239	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000351	0.00239	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000338	0.0023	CbGpPWpGaD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	0.000337	0.00229	CbGpPWpGaD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000337	0.00229	CbGpPWpGaD
Cefuroxime—Headache—Propofol—epilepsy syndrome	0.000329	0.000387	CcSEcCtD
Cefuroxime—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000328	0.000386	CcSEcCtD
Cefuroxime—Chills—Gabapentin—epilepsy syndrome	0.000327	0.000385	CcSEcCtD
Cefuroxime—Vomiting—Midazolam—epilepsy syndrome	0.000326	0.000385	CcSEcCtD
Cefuroxime—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000326	0.000385	CcSEcCtD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.000326	0.00222	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.000326	0.00222	CbGpPWpGaD
Cefuroxime—Chest pain—Valproic Acid—epilepsy syndrome	0.000326	0.000384	CcSEcCtD
Cefuroxime—Arthralgia—Valproic Acid—epilepsy syndrome	0.000326	0.000384	CcSEcCtD
Cefuroxime—Rash—Midazolam—epilepsy syndrome	0.000324	0.000382	CcSEcCtD
Cefuroxime—Dizziness—Fosphenytoin—epilepsy syndrome	0.000323	0.000381	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000323	0.000381	CcSEcCtD
Cefuroxime—Dermatitis—Midazolam—epilepsy syndrome	0.000323	0.000381	CcSEcCtD
Cefuroxime—Urticaria—Carbamazepine—epilepsy syndrome	0.000323	0.000381	CcSEcCtD
Cefuroxime—Vomiting—Levetiracetam—epilepsy syndrome	0.000322	0.00038	CcSEcCtD
Cefuroxime—Headache—Midazolam—epilepsy syndrome	0.000321	0.000379	CcSEcCtD
Cefuroxime—Pruritus—Felbamate—epilepsy syndrome	0.000321	0.000379	CcSEcCtD
Cefuroxime—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000321	0.000379	CcSEcCtD
Cefuroxime—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000321	0.000379	CcSEcCtD
Cefuroxime—Diarrhoea—Diazepam—epilepsy syndrome	0.000321	0.000379	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000321	0.000379	CcSEcCtD
Cefuroxime—Sinusitis—Topiramate—epilepsy syndrome	0.00032	0.000378	CcSEcCtD
Cefuroxime—Rash—Levetiracetam—epilepsy syndrome	0.00032	0.000377	CcSEcCtD
Cefuroxime—Dermatitis—Levetiracetam—epilepsy syndrome	0.000319	0.000376	CcSEcCtD
Cefuroxime—Agranulocytosis—Topiramate—epilepsy syndrome	0.000318	0.000376	CcSEcCtD
Cefuroxime—Agitation—Pregabalin—epilepsy syndrome	0.000318	0.000375	CcSEcCtD
Cefuroxime—Headache—Levetiracetam—epilepsy syndrome	0.000317	0.000374	CcSEcCtD
Cefuroxime—Erythema—Gabapentin—epilepsy syndrome	0.000317	0.000374	CcSEcCtD
Cefuroxime—Angioedema—Pregabalin—epilepsy syndrome	0.000316	0.000372	CcSEcCtD
Cefuroxime—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000316	0.000372	CcSEcCtD
Cefuroxime—Dizziness—Vigabatrin—epilepsy syndrome	0.000315	0.000372	CcSEcCtD
Cefuroxime—Pruritus—Zonisamide—epilepsy syndrome	0.000315	0.000371	CcSEcCtD
Cefuroxime—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000314	0.00037	CcSEcCtD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.000313	0.00213	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000313	0.00213	CbGpPWpGaD
Cefuroxime—Flatulence—Gabapentin—epilepsy syndrome	0.000312	0.000368	CcSEcCtD
Cefuroxime—Cephalexin—CYP2D6—epilepsy syndrome	0.000312	0.0634	CrCbGaD
Cefuroxime—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000312	0.000368	CcSEcCtD
Cefuroxime—Urticaria—Lamotrigine—epilepsy syndrome	0.000312	0.000368	CcSEcCtD
Cefuroxime—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000312	0.000368	CcSEcCtD
Cefuroxime—Nausea—Propofol—epilepsy syndrome	0.000312	0.000367	CcSEcCtD
Cefuroxime—Vomiting—Fosphenytoin—epilepsy syndrome	0.000311	0.000367	CcSEcCtD
Cefuroxime—Diarrhoea—Felbamate—epilepsy syndrome	0.000311	0.000367	CcSEcCtD
Cefuroxime—Body temperature increased—Lamotrigine—epilepsy syndrome	0.00031	0.000366	CcSEcCtD
Cefuroxime—Abdominal pain—Lamotrigine—epilepsy syndrome	0.00031	0.000366	CcSEcCtD
Cefuroxime—Dizziness—Diazepam—epilepsy syndrome	0.00031	0.000366	CcSEcCtD
Cefuroxime—Cefazolin—ALB—epilepsy syndrome	0.00031	0.0628	CrCbGaD
Cefuroxime—Leukopenia—Pregabalin—epilepsy syndrome	0.000309	0.000365	CcSEcCtD
Cefuroxime—Rash—Fosphenytoin—epilepsy syndrome	0.000308	0.000364	CcSEcCtD
Cefuroxime—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000308	0.000363	CcSEcCtD
Cefuroxime—Haemoglobin—Topiramate—epilepsy syndrome	0.000308	0.000363	CcSEcCtD
Cefuroxime—Headache—Fosphenytoin—epilepsy syndrome	0.000306	0.000361	CcSEcCtD
Cefuroxime—Haemorrhage—Topiramate—epilepsy syndrome	0.000306	0.000361	CcSEcCtD
Cefuroxime—Hepatitis—Topiramate—epilepsy syndrome	0.000306	0.000361	CcSEcCtD
Cefuroxime—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000306	0.00036	CcSEcCtD
Cefuroxime—Palpitations—Pregabalin—epilepsy syndrome	0.000305	0.00036	CcSEcCtD
Cefuroxime—Nausea—Midazolam—epilepsy syndrome	0.000305	0.000359	CcSEcCtD
Cefuroxime—Muscle spasms—Gabapentin—epilepsy syndrome	0.000305	0.000359	CcSEcCtD
Cefuroxime—Tachycardia—Valproic Acid—epilepsy syndrome	0.000305	0.000359	CcSEcCtD
Cefuroxime—Diarrhoea—Zonisamide—epilepsy syndrome	0.000304	0.000359	CcSEcCtD
Cefuroxime—Pruritus—Clonazepam—epilepsy syndrome	0.000303	0.000358	CcSEcCtD
Cefuroxime—Vomiting—Vigabatrin—epilepsy syndrome	0.000303	0.000357	CcSEcCtD
Cefuroxime—Skin disorder—Valproic Acid—epilepsy syndrome	0.000303	0.000357	CcSEcCtD
Cefuroxime—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000303	0.000357	CcSEcCtD
Cefuroxime—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000302	0.000356	CcSEcCtD
Cefuroxime—Cough—Pregabalin—epilepsy syndrome	0.000302	0.000356	CcSEcCtD
Cefuroxime—Pruritus—Phenytoin—epilepsy syndrome	0.000301	0.000355	CcSEcCtD
Cefuroxime—Nausea—Levetiracetam—epilepsy syndrome	0.000301	0.000355	CcSEcCtD
Cefuroxime—Rash—Vigabatrin—epilepsy syndrome	0.000301	0.000354	CcSEcCtD
Cefuroxime—Dizziness—Felbamate—epilepsy syndrome	0.0003	0.000354	CcSEcCtD
Cefuroxime—Dermatitis—Vigabatrin—epilepsy syndrome	0.0003	0.000354	CcSEcCtD
Cefuroxime—Urethral disorder—Topiramate—epilepsy syndrome	0.0003	0.000354	CcSEcCtD
Cefuroxime—Pruritus—Oxcarbazepine—epilepsy syndrome	0.0003	0.000353	CcSEcCtD
Cefuroxime—Convulsion—Pregabalin—epilepsy syndrome	0.0003	0.000353	CcSEcCtD
Cefuroxime—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000299	0.000353	CcSEcCtD
Cefuroxime—Headache—Vigabatrin—epilepsy syndrome	0.000299	0.000352	CcSEcCtD
Cefuroxime—Vomiting—Diazepam—epilepsy syndrome	0.000298	0.000352	CcSEcCtD
Cefuroxime—Anorexia—Valproic Acid—epilepsy syndrome	0.000297	0.000351	CcSEcCtD
Cefuroxime—Rash—Diazepam—epilepsy syndrome	0.000296	0.000349	CcSEcCtD
Cefuroxime—Dermatitis—Diazepam—epilepsy syndrome	0.000296	0.000349	CcSEcCtD
Cefuroxime—Arthralgia—Pregabalin—epilepsy syndrome	0.000294	0.000347	CcSEcCtD
Cefuroxime—Chest pain—Pregabalin—epilepsy syndrome	0.000294	0.000347	CcSEcCtD
Cefuroxime—Dizziness—Zonisamide—epilepsy syndrome	0.000294	0.000347	CcSEcCtD
Cefuroxime—Headache—Diazepam—epilepsy syndrome	0.000294	0.000347	CcSEcCtD
Cefuroxime—Ceftriaxone—ALB—epilepsy syndrome	0.000293	0.0595	CrCbGaD
Cefuroxime—Diarrhoea—Clonazepam—epilepsy syndrome	0.000293	0.000346	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000292	0.000345	CcSEcCtD
Cefuroxime—Agitation—Gabapentin—epilepsy syndrome	0.000291	0.000343	CcSEcCtD
Cefuroxime—Diarrhoea—Phenytoin—epilepsy syndrome	0.000291	0.000343	CcSEcCtD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.000291	0.00198	CbGpPWpGaD
Cefuroxime—Nausea—Fosphenytoin—epilepsy syndrome	0.000291	0.000343	CcSEcCtD
Cefuroxime—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.00029	0.000342	CcSEcCtD
Cefuroxime—Erythema multiforme—Topiramate—epilepsy syndrome	0.00029	0.000342	CcSEcCtD
Cefuroxime—Angioedema—Gabapentin—epilepsy syndrome	0.00029	0.000342	CcSEcCtD
Cefuroxime—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000289	0.000341	CcSEcCtD
Cefuroxime—Vomiting—Felbamate—epilepsy syndrome	0.000289	0.000341	CcSEcCtD
Cefuroxime—Pruritus—Carbamazepine—epilepsy syndrome	0.000287	0.000339	CcSEcCtD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	0.000286	0.00195	CbGpPWpGaD
Cefuroxime—Rash—Felbamate—epilepsy syndrome	0.000286	0.000338	CcSEcCtD
Cefuroxime—Dermatitis—Felbamate—epilepsy syndrome	0.000286	0.000337	CcSEcCtD
Cefuroxime—Headache—Felbamate—epilepsy syndrome	0.000285	0.000336	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000284	0.000335	CcSEcCtD
Cefuroxime—Leukopenia—Gabapentin—epilepsy syndrome	0.000284	0.000335	CcSEcCtD
Cefuroxime—Dizziness—Clonazepam—epilepsy syndrome	0.000283	0.000334	CcSEcCtD
Cefuroxime—Nausea—Vigabatrin—epilepsy syndrome	0.000283	0.000334	CcSEcCtD
Cefuroxime—Vomiting—Zonisamide—epilepsy syndrome	0.000283	0.000333	CcSEcCtD
Cefuroxime—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000282	0.000333	CcSEcCtD
Cefuroxime—Dizziness—Phenytoin—epilepsy syndrome	0.000281	0.000332	CcSEcCtD
Cefuroxime—Rash—Zonisamide—epilepsy syndrome	0.00028	0.000331	CcSEcCtD
Cefuroxime—Palpitations—Gabapentin—epilepsy syndrome	0.00028	0.00033	CcSEcCtD
Cefuroxime—Dermatitis—Zonisamide—epilepsy syndrome	0.00028	0.00033	CcSEcCtD
Cefuroxime—Dizziness—Oxcarbazepine—epilepsy syndrome	0.00028	0.00033	CcSEcCtD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	0.000279	0.0019	CbGpPWpGaD
Cefuroxime—Nausea—Diazepam—epilepsy syndrome	0.000279	0.000329	CcSEcCtD
Cefuroxime—Headache—Zonisamide—epilepsy syndrome	0.000279	0.000328	CcSEcCtD
Cefuroxime—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000278	0.000328	CcSEcCtD
Cefuroxime—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000278	0.000328	CcSEcCtD
Cefuroxime—Angiopathy—Topiramate—epilepsy syndrome	0.000278	0.000328	CcSEcCtD
Cefuroxime—Pruritus—Lamotrigine—epilepsy syndrome	0.000278	0.000328	CcSEcCtD
Cefuroxime—Somnolence—Valproic Acid—epilepsy syndrome	0.000277	0.000327	CcSEcCtD
Cefuroxime—Immune system disorder—Topiramate—epilepsy syndrome	0.000277	0.000326	CcSEcCtD
Cefuroxime—Cough—Gabapentin—epilepsy syndrome	0.000277	0.000326	CcSEcCtD
Cefuroxime—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000276	0.000326	CcSEcCtD
Cefuroxime—Tachycardia—Pregabalin—epilepsy syndrome	0.000275	0.000325	CcSEcCtD
Cefuroxime—Chills—Topiramate—epilepsy syndrome	0.000275	0.000324	CcSEcCtD
Cefuroxime—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000275	0.000324	CcSEcCtD
Cefuroxime—Convulsion—Gabapentin—epilepsy syndrome	0.000275	0.000324	CcSEcCtD
Cefuroxime—Skin disorder—Pregabalin—epilepsy syndrome	0.000274	0.000323	CcSEcCtD
Cefuroxime—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000273	0.000322	CcSEcCtD
Cefuroxime—Vomiting—Clonazepam—epilepsy syndrome	0.000272	0.000321	CcSEcCtD
Cefuroxime—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000271	0.00032	CcSEcCtD
Cefuroxime—Vomiting—Phenytoin—epilepsy syndrome	0.000271	0.000319	CcSEcCtD
Cefuroxime—Rash—Clonazepam—epilepsy syndrome	0.00027	0.000319	CcSEcCtD
Cefuroxime—Dermatitis—Clonazepam—epilepsy syndrome	0.00027	0.000318	CcSEcCtD
Cefuroxime—Arthralgia—Gabapentin—epilepsy syndrome	0.00027	0.000318	CcSEcCtD
Cefuroxime—Chest pain—Gabapentin—epilepsy syndrome	0.00027	0.000318	CcSEcCtD
Cefuroxime—Nausea—Felbamate—epilepsy syndrome	0.00027	0.000318	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000269	0.000318	CcSEcCtD
Cefuroxime—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000269	0.000317	CcSEcCtD
Cefuroxime—Anorexia—Pregabalin—epilepsy syndrome	0.000269	0.000317	CcSEcCtD
Cefuroxime—Dizziness—Carbamazepine—epilepsy syndrome	0.000269	0.000317	CcSEcCtD
Cefuroxime—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000269	0.000317	CcSEcCtD
Cefuroxime—Headache—Clonazepam—epilepsy syndrome	0.000268	0.000317	CcSEcCtD
Cefuroxime—Rash—Phenytoin—epilepsy syndrome	0.000268	0.000316	CcSEcCtD
Cefuroxime—Dermatitis—Phenytoin—epilepsy syndrome	0.000268	0.000316	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000268	0.000316	CcSEcCtD
Cefuroxime—Rash—Oxcarbazepine—epilepsy syndrome	0.000267	0.000315	CcSEcCtD
Cefuroxime—Pain—Valproic Acid—epilepsy syndrome	0.000267	0.000315	CcSEcCtD
Cefuroxime—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000267	0.000315	CcSEcCtD
Cefuroxime—Headache—Phenytoin—epilepsy syndrome	0.000267	0.000314	CcSEcCtD
Cefuroxime—Erythema—Topiramate—epilepsy syndrome	0.000267	0.000314	CcSEcCtD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	0.000266	0.00181	CbGpPWpGaD
Cefuroxime—Headache—Oxcarbazepine—epilepsy syndrome	0.000265	0.000313	CcSEcCtD
Cefuroxime—Nausea—Zonisamide—epilepsy syndrome	0.000264	0.000311	CcSEcCtD
Cefuroxime—Flatulence—Topiramate—epilepsy syndrome	0.000263	0.00031	CcSEcCtD
Cefuroxime—Dizziness—Lamotrigine—epilepsy syndrome	0.00026	0.000306	CcSEcCtD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	0.000259	0.00176	CbGpPWpGaD
Cefuroxime—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000259	0.000305	CcSEcCtD
Cefuroxime—Vomiting—Carbamazepine—epilepsy syndrome	0.000258	0.000305	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000257	0.000303	CcSEcCtD
Cefuroxime—Cefalotin—ALB—epilepsy syndrome	0.000257	0.0521	CrCbGaD
Cefuroxime—Muscle spasms—Topiramate—epilepsy syndrome	0.000256	0.000302	CcSEcCtD
Cefuroxime—Rash—Carbamazepine—epilepsy syndrome	0.000256	0.000302	CcSEcCtD
Cefuroxime—Dermatitis—Carbamazepine—epilepsy syndrome	0.000256	0.000302	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000255	0.000301	CcSEcCtD
Cefuroxime—Nausea—Clonazepam—epilepsy syndrome	0.000255	0.0003	CcSEcCtD
Cefuroxime—Headache—Carbamazepine—epilepsy syndrome	0.000255	0.0003	CcSEcCtD
Cefuroxime—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000253	0.000299	CcSEcCtD
Cefuroxime—Nausea—Phenytoin—epilepsy syndrome	0.000253	0.000298	CcSEcCtD
Cefuroxime—Tachycardia—Gabapentin—epilepsy syndrome	0.000252	0.000298	CcSEcCtD
Cefuroxime—Dyspnoea—Pregabalin—epilepsy syndrome	0.000252	0.000297	CcSEcCtD
Cefuroxime—Nausea—Oxcarbazepine—epilepsy syndrome	0.000252	0.000297	CcSEcCtD
Cefuroxime—Skin disorder—Gabapentin—epilepsy syndrome	0.000251	0.000296	CcSEcCtD
Cefuroxime—Somnolence—Pregabalin—epilepsy syndrome	0.000251	0.000296	CcSEcCtD
Cefuroxime—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.00025	0.000295	CcSEcCtD
Cefuroxime—Vomiting—Lamotrigine—epilepsy syndrome	0.00025	0.000294	CcSEcCtD
Cefuroxime—Urticaria—Valproic Acid—epilepsy syndrome	0.000248	0.000292	CcSEcCtD
Cefuroxime—Rash—Lamotrigine—epilepsy syndrome	0.000248	0.000292	CcSEcCtD
Cefuroxime—Dermatitis—Lamotrigine—epilepsy syndrome	0.000247	0.000292	CcSEcCtD
Cefuroxime—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000247	0.000291	CcSEcCtD
Cefuroxime—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000247	0.000291	CcSEcCtD
Cefuroxime—Anorexia—Gabapentin—epilepsy syndrome	0.000247	0.000291	CcSEcCtD
Cefuroxime—Headache—Lamotrigine—epilepsy syndrome	0.000246	0.00029	CcSEcCtD
Cefuroxime—Decreased appetite—Pregabalin—epilepsy syndrome	0.000245	0.000289	CcSEcCtD
Cefuroxime—Agitation—Topiramate—epilepsy syndrome	0.000245	0.000289	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000244	0.000287	CcSEcCtD
Cefuroxime—Nausea—Carbamazepine—epilepsy syndrome	0.000241	0.000285	CcSEcCtD
Cefuroxime—Pain—Pregabalin—epilepsy syndrome	0.000241	0.000284	CcSEcCtD
Cefuroxime—Leukopenia—Topiramate—epilepsy syndrome	0.000239	0.000281	CcSEcCtD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	0.000237	0.00161	CbGpPWpGaD
Cefuroxime—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000236	0.000278	CcSEcCtD
Cefuroxime—Palpitations—Topiramate—epilepsy syndrome	0.000236	0.000278	CcSEcCtD
Cefuroxime—Cephalexin—ALB—epilepsy syndrome	0.000234	0.0474	CrCbGaD
Cefuroxime—Nausea—Lamotrigine—epilepsy syndrome	0.000233	0.000275	CcSEcCtD
Cefuroxime—Cough—Topiramate—epilepsy syndrome	0.000233	0.000274	CcSEcCtD
Cefuroxime—Convulsion—Topiramate—epilepsy syndrome	0.000231	0.000272	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000231	0.000272	CcSEcCtD
Cefuroxime—Dyspnoea—Gabapentin—epilepsy syndrome	0.000231	0.000272	CcSEcCtD
Cefuroxime—Somnolence—Gabapentin—epilepsy syndrome	0.00023	0.000271	CcSEcCtD
Cefuroxime—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.00023	0.000271	CcSEcCtD
Cefuroxime—Dyspepsia—Gabapentin—epilepsy syndrome	0.000228	0.000269	CcSEcCtD
Cefuroxime—Arthralgia—Topiramate—epilepsy syndrome	0.000227	0.000268	CcSEcCtD
Cefuroxime—Chest pain—Topiramate—epilepsy syndrome	0.000227	0.000268	CcSEcCtD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	0.000226	0.00154	CbGpPWpGaD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000225	0.000266	CcSEcCtD
Cefuroxime—Decreased appetite—Gabapentin—epilepsy syndrome	0.000225	0.000265	CcSEcCtD
Cefuroxime—Urticaria—Pregabalin—epilepsy syndrome	0.000224	0.000264	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000223	0.000263	CcSEcCtD
Cefuroxime—Abdominal pain—Pregabalin—epilepsy syndrome	0.000223	0.000263	CcSEcCtD
Cefuroxime—Body temperature increased—Pregabalin—epilepsy syndrome	0.000223	0.000263	CcSEcCtD
Cefuroxime—Pain—Gabapentin—epilepsy syndrome	0.000221	0.000261	CcSEcCtD
Cefuroxime—Pruritus—Valproic Acid—epilepsy syndrome	0.000221	0.00026	CcSEcCtD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	0.00022	0.0015	CbGpPWpGaD
Cefuroxime—SLC15A2—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	0.00022	0.0015	CbGpPWpGaD
Cefuroxime—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000214	0.000252	CcSEcCtD
Cefuroxime—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000213	0.000251	CcSEcCtD
Cefuroxime—Tachycardia—Topiramate—epilepsy syndrome	0.000212	0.00025	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000212	0.000249	CcSEcCtD
Cefuroxime—Skin disorder—Topiramate—epilepsy syndrome	0.000211	0.000249	CcSEcCtD
Cefuroxime—Hyperhidrosis—Topiramate—epilepsy syndrome	0.00021	0.000248	CcSEcCtD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	0.00021	0.00143	CbGpPWpGaD
Cefuroxime—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000208	0.000245	CcSEcCtD
Cefuroxime—Anorexia—Topiramate—epilepsy syndrome	0.000207	0.000245	CcSEcCtD
Cefuroxime—Dizziness—Valproic Acid—epilepsy syndrome	0.000206	0.000243	CcSEcCtD
Cefuroxime—Urticaria—Gabapentin—epilepsy syndrome	0.000206	0.000242	CcSEcCtD
Cefuroxime—Abdominal pain—Gabapentin—epilepsy syndrome	0.000205	0.000241	CcSEcCtD
Cefuroxime—Body temperature increased—Gabapentin—epilepsy syndrome	0.000205	0.000241	CcSEcCtD
Cefuroxime—SLC15A1—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	0.000204	0.00139	CbGpPWpGaD
Cefuroxime—Pruritus—Pregabalin—epilepsy syndrome	0.0002	0.000235	CcSEcCtD
Cefuroxime—Vomiting—Valproic Acid—epilepsy syndrome	0.000198	0.000234	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000198	0.000234	CcSEcCtD
Cefuroxime—Rash—Valproic Acid—epilepsy syndrome	0.000197	0.000232	CcSEcCtD
Cefuroxime—Dermatitis—Valproic Acid—epilepsy syndrome	0.000197	0.000232	CcSEcCtD
Cefuroxime—Headache—Valproic Acid—epilepsy syndrome	0.000195	0.000231	CcSEcCtD
Cefuroxime—Dyspnoea—Topiramate—epilepsy syndrome	0.000194	0.000229	CcSEcCtD
Cefuroxime—Somnolence—Topiramate—epilepsy syndrome	0.000193	0.000228	CcSEcCtD
Cefuroxime—Diarrhoea—Pregabalin—epilepsy syndrome	0.000193	0.000228	CcSEcCtD
Cefuroxime—Dyspepsia—Topiramate—epilepsy syndrome	0.000192	0.000226	CcSEcCtD
Cefuroxime—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000191	0.000225	CcSEcCtD
Cefuroxime—Decreased appetite—Topiramate—epilepsy syndrome	0.000189	0.000223	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000188	0.000222	CcSEcCtD
Cefuroxime—Dizziness—Pregabalin—epilepsy syndrome	0.000187	0.00022	CcSEcCtD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	0.000186	0.00127	CbGpPWpGaD
Cefuroxime—Pain—Topiramate—epilepsy syndrome	0.000186	0.000219	CcSEcCtD
Cefuroxime—Nausea—Valproic Acid—epilepsy syndrome	0.000185	0.000219	CcSEcCtD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	0.000185	0.00126	CbGpPWpGaD
Cefuroxime—Pruritus—Gabapentin—epilepsy syndrome	0.000183	0.000216	CcSEcCtD
Cefuroxime—Vomiting—Pregabalin—epilepsy syndrome	0.000179	0.000212	CcSEcCtD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	0.000179	0.00122	CbGpPWpGaD
Cefuroxime—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000178	0.00021	CcSEcCtD
Cefuroxime—Rash—Pregabalin—epilepsy syndrome	0.000178	0.00021	CcSEcCtD
Cefuroxime—Dermatitis—Pregabalin—epilepsy syndrome	0.000178	0.00021	CcSEcCtD
Cefuroxime—Diarrhoea—Gabapentin—epilepsy syndrome	0.000177	0.000209	CcSEcCtD
Cefuroxime—Headache—Pregabalin—epilepsy syndrome	0.000177	0.000208	CcSEcCtD
Cefuroxime—Urticaria—Topiramate—epilepsy syndrome	0.000173	0.000204	CcSEcCtD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	0.000173	0.00118	CbGpPWpGaD
Cefuroxime—Body temperature increased—Topiramate—epilepsy syndrome	0.000172	0.000203	CcSEcCtD
Cefuroxime—Abdominal pain—Topiramate—epilepsy syndrome	0.000172	0.000203	CcSEcCtD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	0.000171	0.00117	CbGpPWpGaD
Cefuroxime—Dizziness—Gabapentin—epilepsy syndrome	0.000171	0.000202	CcSEcCtD
Cefuroxime—Nausea—Pregabalin—epilepsy syndrome	0.000168	0.000198	CcSEcCtD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	0.000166	0.00113	CbGpPWpGaD
Cefuroxime—Vomiting—Gabapentin—epilepsy syndrome	0.000164	0.000194	CcSEcCtD
Cefuroxime—Rash—Gabapentin—epilepsy syndrome	0.000163	0.000192	CcSEcCtD
Cefuroxime—Dermatitis—Gabapentin—epilepsy syndrome	0.000163	0.000192	CcSEcCtD
Cefuroxime—Headache—Gabapentin—epilepsy syndrome	0.000162	0.000191	CcSEcCtD
Cefuroxime—Hypersensitivity—Topiramate—epilepsy syndrome	0.00016	0.000189	CcSEcCtD
Cefuroxime—Pruritus—Topiramate—epilepsy syndrome	0.000154	0.000182	CcSEcCtD
Cefuroxime—Nausea—Gabapentin—epilepsy syndrome	0.000154	0.000181	CcSEcCtD
Cefuroxime—Diarrhoea—Topiramate—epilepsy syndrome	0.000149	0.000176	CcSEcCtD
Cefuroxime—Dizziness—Topiramate—epilepsy syndrome	0.000144	0.00017	CcSEcCtD
Cefuroxime—Vomiting—Topiramate—epilepsy syndrome	0.000138	0.000163	CcSEcCtD
Cefuroxime—Rash—Topiramate—epilepsy syndrome	0.000137	0.000162	CcSEcCtD
Cefuroxime—Dermatitis—Topiramate—epilepsy syndrome	0.000137	0.000162	CcSEcCtD
Cefuroxime—Headache—Topiramate—epilepsy syndrome	0.000136	0.000161	CcSEcCtD
Cefuroxime—Nausea—Topiramate—epilepsy syndrome	0.000129	0.000152	CcSEcCtD
Cefuroxime—SLC15A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	0.000112	0.000761	CbGpPWpGaD
Cefuroxime—SLC15A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	0.000104	0.000706	CbGpPWpGaD
